News and Announcements
3 Steps Every Experienced Founder Knows On Raising Capital
- Published December 20, 2022 1:45AM UTC
- Publisher Leila Oliveira
- Categories Capital Raising Tips
There are 3 steps every experienced founder knows about raising capital…
That first-time founders (normally) don’t.
Want them? Here they are…👇🏻
Experienced founder: Is always communicating with investors.
Inexperienced founder: Just talks to investors when need more money.
Experienced founder: Has a clear plan and budget to raise capital.
Inexperienced founder: Sends a cold e-mail to a list of investors and doesn’t know what to do next.
Experienced founder: Uses a CRM to manage investors and an intelligent deal room
Inexperienced founder: Doesn’t keep track of investors’ interactions
So, remember…
Focus on what’s important in the business
and have an intelligent software helping you in the background.
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
